| Old Articles: <Older 3841-3850 Newer> |
 |
Managed Care June 2007 |
Seventy Percent Surge In Diabetes Spending Spending on endocrine and diabetes therapies could surge nearly 70% in the next two years, according to research. Diabetes treatments were the second leading contributor in total dollars to prescription drug spending growth in 2006.  |
Managed Care June 2007 |
Nations Rated On Health Care Despite having the costliest health care system in the world, the United States ranks last compared with five other affluent countries on measures of quality, access, efficiency, equity, and outcomes, according to a survey analysis.  |
Managed Care June 2007 Thomas Morrow |
Dendritic Cell Vaccine Hits FDA Roadblock Questions about study design and analysis prompted the FDA to postpone action on Provenge, a treatment for advanced prostate cancer.  |
Fast Company July 1, 2007 Tinker Ready |
Can CEOs Cure Cancer? Big Pharma execs may not know more about the disease than the rest of us, but a group of them are using their power to fight it.  |
BusinessWeek July 9, 2007 Kerry Capell |
The French Lesson In Health Care The French health care system - a complex mix of private and public financing - offers valuable lessons for would-be health-care reformers in the U.S.  |
BusinessWeek July 9, 2007 Catherine Arnst |
The Doctor Will See You--In Three Months Waiting for doctor appointments is definitely a problem in the U.S., especially for basic care.  |
The Motley Fool June 29, 2007 Brian Orelli |
The Phase 2 Blues Drug developer Cytokinetics disappoints investors with failed clinical trials.  |
The Motley Fool June 29, 2007 Rich Duprey |
No More Mr. NICE Guy Pharmaceuticals take British advisory agency to court to approve Alzheimer's treatment.  |
The Motley Fool June 29, 2007 Brian Lawler |
Genentech's All Good The biotech's latest partnership deal is nothing to worry about. Investors, take note.  |
Chemistry World June 28, 2007 Hepeng Jia |
First Internationally Licensed Chinese Herbal Patent China has licensed its first herbal compound patent to an overseas pharmaceutical company.  |
| <Older 3841-3850 Newer> Return to current articles. |